国际医药卫生导报2011年第17卷第05期IMHGN,January2011,Vo1.17No,0536(9}493.【5】吴家豪,何劲松,倪勇,等.乳腺癌新辅助化疗疗效评价方法进展『J1.癌症,2010,29(22}240—244.【6】WatanabeMA,OdaJM,AmaranteMK,eta1.Regula—toryTcellsandbreastcancer:implicationsforimmunopathogenesis[J].CancerMetastasisRev,2010,29f41:569-579.[7】ChinYR,TokerA.Akt2regulatesexpressionoftheae-tin-bundlingproteinpalladin[J].FEBSLett,2010,584(23):4769—4774.[8]ChenX,HamanoR,SubleskiJJ,eta1.ExpressionofeostimulatoryTNFR2inducesresiManeeofCD4+FoxP3-conventionalTcellstosuppressionbyCD4+FoxP3+regulatoryTcells[J].JImmunol,2010,185f11:174—182.卡他性中耳炎176例分析姜涛[9]TanSX,NgY,JamesDE.AktinhibitorsreduceglucoseuptakeindependentlyoftheireffectsonAkt[J].BiochemJ,2010,432(1):191-197.f1O]尹洪芳,王韫宏,秦小琪,等.新辅助化疗对乳腺癌的组织学分级和生物学指标表达的影响【JJ.中华病理学杂志,2009,31f11858—865.[11]王瑾,郑芹,杨惠玲.乳腺癌细胞三种肿瘤标记物表达及其与临床病理特征相